CAROLINE VICKERS: Open Payments
NPI 1497127641 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 29 payments from 11 companies in 2025. Trend: 2023 $1,170 · 2024 $845 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $149 |
| PFIZER INC. | 5 | $130 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Astellas Pharma US Inc | 2 | $61 |
| Hologic Sales and Service, LLC | 2 | $50 |
| Amgen Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Novo Nordisk Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: NURTEC ODT, QULIPTA, SHINGRIX, UBRELVY, Veozah, APTIMA, GARDASIL 9, TRELEGY ELLIPTA.
Industry payments across CO — which companies pay providers there.
